[1]
|
Williams, R., Karuranga, S., Malanda, B., et al. (2020) Global and Regional Estimates and Projections of Diabetes-Related Health Expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice, 162, Article ID: 108072. https://doi.org/10.1016/j.diabres.2020.108072
|
[2]
|
王伟达, 李昭君, 陈园园, 等. LncRNA与慢性肾脏病的研究进展[J]. 药学学报, 2019, 54(11): 1918-1925.
|
[3]
|
Lin, Y.C., Chang, Y.H., Yang, S.Y., Wu, K.D. and Chu, T.S. (2018) Update of Pathophysiology and Management of Diabetic Kidney Disease. Journal of the Formosan Medical Association, 117, 662-675.
https://doi.org/10.1016/j.jfma.2018.02.007
|
[4]
|
Leti, F. and DiStefano, J.K. (2017) Long Noncoding RNAs as Diagnostic and Therapeutic Targets in Type 2 Diabetes and Related Complications. Genes (Basel), 8, 207. https://doi.org/10.3390/genes8080207
|
[5]
|
Uesaka, M., Nishimura, O., Go, Y., Nakashima, K., Agata, K. and Imamura, T. (2014) Bidirectional Promoters Are the Major Source of Gene Activation-Associated Non-Coding RNAs in Mammals. BMC Genomics, 15, Article No. 35.
https://doi.org/10.1186/1471-2164-15-35
|
[6]
|
Mirza, A.H., Kaur, S., Brorsson, C.A. and Pociot, F. (2014) Effects of GWAS-Associated Genetic Variants on LncRNAs within IBD and T1D Candidate Loci. PLoS ONE, 9, e105723. https://doi.org/10.1371/journal.pone.0105723
|
[7]
|
Ebadi, Z., Moradi, N., Kazemi Fard, T., et al. (2019) Captopril and Spironolactone Can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting microRNA-192 and microRNA-29a/b/c. DNA and Cell Biology, 38, 1134-1142.
https://doi.org/10.1089/dna.2019.4732
|
[8]
|
Yang, Y., Lv, X., Fan, Q., et al. (2019) Analysis of Circulating LncRNA Expression Profiles in Patients with Diabetes Mellitus and Diabetic Nephropathy: Differential Expression Profile of Circulating LncRNA. Clinical Nephrology, 92, 25-35. https://doi.org/10.5414/CN109525
|
[9]
|
Alvarez, M.L. and DiStefano, J.K. (2011) Functional Characterization of the Plasmacytoma Variant Translocation 1 Gene (PVT1) in Diabetic Nephropathy. PLoS ONE, 6, e18671. https://doi.org/10.1371/journal.pone.0018671
|
[10]
|
Qin, B. and Cao, X. (2021) LncRNA PVT1 Regulates High Glucose-Induced Viability, Oxidative Stress, Fibrosis, and Inflammation in Diabetic Nephropathy via miR-325-3p/Snail1 Axis. Diabetes, Metabolic Syndrome and Obesity, 14, 1741-1750. https://doi.org/10.2147/DMSO.S303151
|
[11]
|
Zhong, W., Zeng, J., Xue, J., Du, A. and Xu, Y. (2020) Knockdown of LncRNA PVT1 Alleviates High Glucose-Induced Proliferation and Fibrosis in Human Mesangial Cells by miR-23b-3p/WT1 Axis. Diabetology & Metabolic Syndrome, 12, 33. https://doi.org/10.1186/s13098-020-00539-x
|
[12]
|
Yu, D., Yang, X., Zhu, Y., Xu, F., Zhang, H. and Qiu, Z. (2021) Knockdown of Plasmacytoma Variant Translocation 1 (PVT1) Inhibits High Glucose-Induced Proliferation and Renal Fibrosis in HRMCs by Regulating miR-23b-3p/Early Growth Response Factor 1 (EGR1). Endocrine Journal, 68, 519-529. https://doi.org/10.1507/endocrj.EJ20-0642
|
[13]
|
Guan, Y., Kuo, W.L., Stilwell, J.L., et al. (2007) Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer. Clinical Cancer Research, 13, 5745-5755. https://doi.org/10.1158/1078-0432.CCR-06-2882
|
[14]
|
Liu, D.W., Zhang, J.H., Liu, F.X., et al. (2019) Silencing of Long Noncoding RNA PVT1 Inhibits Podocyte Damage and Apoptosis in Diabetic Nephropathy by Upregulating FOXA1. Experimental & Molecular Medicine, 51, 88.
https://doi.org/10.1038/s12276-019-0259-6
|
[15]
|
Yan, B., Tao, Z.F., Li, X.M., Zhang, H., Yao, J. and Jiang, Q. (2014) Aberrant Expression of Long Noncoding RNAs in Early Diabetic Retinopathy. Investigative Ophthalmology & Visual Science, 55, 941-951.
https://doi.org/10.1167/iovs.13-13221
|
[16]
|
Hu, M., Wang, R., Li, X., et al. (2017) LncRNA MALAT1 Is Dysregulated in Diabetic Nephropathy and Involved in High Glucose-Induced Podocyte Injury via Its Interplay with β-Catenin. Journal of Cellular and Molecular Medicine, 21, 2732-2747. https://doi.org/10.1111/jcmm.13189
|
[17]
|
Gong, Q. and Su, G. (2017) Roles of miRNAs and Long Noncoding RNAs in the Progression of Diabetic Retinopathy. Bioscience Reports, 37, BSR20171157. https://doi.org/10.1042/BSR20171157
|
[18]
|
Lelli, A., Nolan, K.A., Santambrogio, S., et al. (2015) Induction of Long Noncoding RNA MALAT1 in Hypoxic Mice. Hypoxia (Auckl.), 3, 45-52. https://doi.org/10.2147/HP.S90555
|
[19]
|
Li, X., Zeng, L., Cao, C., et al. (2017) Long Noncoding RNA MALAT1 Regulates Renal Tubular Epithelial Pyroptosis by Modulated miR-23c Targeting of ELAVL1 in Diabetic Nephropathy. Experimental Cell Research, 350, 327-335.
https://doi.org/10.1016/j.yexcr.2016.12.006
|
[20]
|
Liu, C., Zhuo, H., Ye, M.Y., Huang, G.X., Fan, M. and Huang, X.Z. (2020) LncRNA MALAT1 Promoted High Glucose-Induced Pyroptosis of Renal Tubular Epithelial Cell by Sponging miR-30c Targeting for NLRP3. The Kaohsiung Journal of Medical Sciences, 36, 682-691. https://doi.org/10.1002/kjm2.12226
|
[21]
|
Feng, Y., Chen, S., Xu, J., et al. (2018) Dysregulation of LncRNAs GM5524 and GM15645 Involved in High-Glucose-Induced Podocyte Apoptosis and Autophagy in Diabetic Nephropathy. Molecular Medicine Reports, 18, 3657-3664. https://doi.org/10.3892/mmr.2018.9412
|
[22]
|
Qian, X., Tan, J., Liu, L., et al. (2018) MicroRNA-134-5p Promotes High Glucose-Induced Podocyte Apoptosis by Targeting bcl-2. The American Journal of Translational Research, 10, 989-997.
|
[23]
|
Zhang, X., Song, S. and Luo, H. (2016) Regulation of Podocyte Lesions in Diabetic Nephropathy via miR-34a in the Notch Signaling Pathway. Medicine (Baltimore), 95, e5050. https://doi.org/10.1097/MD.0000000000005050
|
[24]
|
Yi, H., Peng, R., Zhang, L.Y., et al. (2017) LincRNA-Gm4419 Knockdown Ameliorates NF-κB/NLRP3 Inflammasome-Mediated Inflammation in Diabetic Nephropathy. Cell Death & Disease, 8, e2583.
https://doi.org/10.1038/cddis.2016.451
|
[25]
|
Li, H., Wu, P., Sun, D., et al. (2020) LncRNA-Gm4419 Alleviates Renal Damage in Rats with Diabetic Nephropathy through NF-κB Pathway. Panminerva Medica. https://doi.org/10.23736/S0031-0808.19.03844-8
|
[26]
|
Kato, M., Wang, M., Chen, Z., et al. (2016) An Endoplasmic Reticulum Stress-Regulated LncRNA Hosting a microRNA Megacluster Induces Early Features of Diabetic Nephropathy. Nature Communications, 7, Article No. 12864.
https://doi.org/10.1038/ncomms12864
|
[27]
|
Sun, S.F., Tang, P.M.K., Feng, M., et al. (2018) Novel LncRNA Erbb4-IR Promotes Diabetic Kidney Injury in db/db Mice by Targeting miR-29b. Diabetes, 67, 731-744. https://doi.org/10.2337/db17-0816
|
[28]
|
Feng, M., Tang, P.M., Huang, X.R., et al. (2018) TGF-β Mediates Renal Fibrosis via the Smad3-Erbb4-IR Long Noncoding RNA Axis. Molecular Therapy, 26, 148-161. https://doi.org/10.1016/j.ymthe.2017.09.024
|
[29]
|
Li, S.Y. and Susztak, K. (2016) The Long Noncoding RNA Tug1 Connects Metabolic Changes with Kidney Disease in Podocytes. Journal of Clinical Investigation, 126, 4072-4075. https://doi.org/10.1172/JCI90828
|
[30]
|
Long, J., Badal, S.S., Ye, Z., et al. (2016) Long Noncoding RNA Tug1 Regulates Mitochondrial Bioenergetics in Diabetic Nephropathy. Journal of Clinical Investigation, 126, 4205-4218. https://doi.org/10.1172/JCI87927
|
[31]
|
Duan, L.J., Ding, M., Hou, L.J., Cui, Y.T., Li, C.J. and Yu, D.M. (2017) Long Noncoding RNA TUG1 Alleviates Extracellular Matrix Accumulation via Mediating microRNA-377 Targeting of PPARγ in Diabetic Nephropathy. Biochemical and Biophysical Research Communications, 484, 598-604. https://doi.org/10.1016/j.bbrc.2017.01.145
|
[32]
|
Lei, X., Zhang, L., Li, Z. and Ren, J. (2018) Astragaloside IV/LncRNA-TUG1/TRAF5 Signaling Pathway Participates in Podocyte Apoptosis of Diabetic Nephropathy Rats. Drug Design, Development and Therapy, 12, 2785-2793.
https://doi.org/10.2147/DDDT.S166525
|
[33]
|
Zang, X.J., Li, L., Du, X., Yang, B. and Mei, C.L. (2019) LncRNA TUG1 Inhibits the Proliferation and Fibrosis of Mesangial Cells in Diabetic Nephropathy via Inhibiting the PI3K/AKT Pathway. European Review for Medical and Pharmacological Sciences, 23, 7519-7525.
|
[34]
|
Meng, D., Wu, L., Li, Z., et al. (2021) LncRNA TUG1 Ameliorates Diabetic Nephropathy via Inhibition of PU.1/RTN1 Signaling Pathway. Journal of Leukocyte Biology. https://doi.org/10.1002/JLB.6A1020-699RRR
|
[35]
|
Wang, S., Yi, P., Wang, N., Song, M., Li, W. and Zheng, Y. (2021) LncRNA TUG1/miR-29c-3p/SIRT1 Axis Regulates Endoplasmic Reticulum Stress-Mediated Renal Epithelial Cells Injury in Diabetic Nephropathy Model in Vitro. PLoS ONE, 16, e0252761. https://doi.org/10.1371/journal.pone.0252761
|
[36]
|
Zhou, L., Xu, D.Y., Sha, W.G., Shen, L., Lu, G.Y. and Yin, X. (2015) Long Non-Coding MIAT Mediates High Glucose-Induced Renal Tubular Epithelial Injury. Biochemical and Biophysical Research Communications, 468, 726-732.
https://doi.org/10.1016/j.bbrc.2015.11.023
|
[37]
|
Xiao, L., Xu, X., Zhang, F., et al. (2017) The Mitochondria-Targeted Antioxidant MitoQ Ameliorated Tubular Injury Mediated by Mitophagy in Diabetic Kidney Disease via Nrf2/PINK1. Redox Biology, 11, 297-311.
https://doi.org/10.1016/j.redox.2016.12.022
|
[38]
|
Ji, T.T., Qi, Y.H., Li, X.Y., et al. (2020) Loss of LncRNA MIAT Ameliorates Proliferation and Fibrosis of Diabetic nephropathy through Reducing E2F3 Expression. Journal of Cellular and Molecular Medicine, 24, 13314-13323.
https://doi.org/10.1111/jcmm.15949
|
[39]
|
Dong, Q., Wang, Q., Yan, X., Wang, X., Li, Z. and Zhang, L. (2021) Long Noncoding RNA MIAT Inhibits the Progression of Diabetic Nephropathy and the Activation of NF-κB Pathway in High Glucose-Treated Renal Tubular Epithelial Cells by the miR-182-5p/GPRC5A Axis. Open Medicine (Wars), 16, 1336-1349.
https://doi.org/10.1515/med-2021-0328
|
[40]
|
Zhang, M., Zhao, S., Xu, C., et al. (2020) Ablation of LncRNA MIAT Mitigates High Glucose-Stimulated Inflammation and Apoptosis of Podocyte via miR-130a-3p/TLR4 Signaling Axis. Biochemical and Biophysical Research Communications, 533, 429-436. https://doi.org/10.1016/j.bbrc.2020.09.034
|
[41]
|
Wang, M., Wang, S., Yao, D., Yan, Q. and Lu, W. (2016) A Novel Long Non-Coding RNA CYP4B1-PS1-001 Regulates Proliferation and Fibrosis in Diabetic Nephropathy. Molecular and Cellular Endocrinology, 426, 136-145.
https://doi.org/10.1016/j.mce.2016.02.020
|
[42]
|
Wang, S., Chen, X., Wang, M., et al. (2018) Long Non-Coding RNA CYP4B1-PS1-001 Inhibits Proliferation and Fibrosis in Diabetic Nephropathy by Interacting with Nucleolin. Cellular Physiology and Biochemistry, 49, 2174-2187.
https://doi.org/10.1159/000493821
|
[43]
|
Bai, X., Geng, J., Li, X., et al. (2018) Long Noncoding RNA LINC01619 Regulates MicroRNA-27a/Forkhead Box Protein O1 and Endoplasmic Reticulum Stress-Mediated Podocyte Injury in Diabetic Nephropathy. Antioxidants & Redox Signaling, 29, 355-376. https://doi.org/10.1089/ars.2017.7278
|
[44]
|
Zhou, L.J., Yang, D.W., Ou, L.N., Guo, X.R. and Wu, B.L. (2020) Circulating Expression Level of LncRNA Malat1 in Diabetic Kidney Disease Patients and Its Clinical Significance. Journal of Diabetes Research, 2020, Article ID: 4729019. https://doi.org/10.1155/2020/4729019
|
[45]
|
Petrica, L., Hogea, E., Gadalean, F., et al. (2021) Long Noncoding RNAs May Impact Podocytes and Proximal Tubule Function through Modulating miRNAs Expression in Early Diabetic Kidney Disease of Type 2 Diabetes Mellitus Patients. International Journal of Medical Sciences, 18, 2093-2101. https://doi.org/10.7150/ijms.56551
|
[46]
|
Wang, L., Su, N., Zhang, Y. and Wang, G. (2018) Clinical Significance of Serum LncRNA Cancer Susceptibility Candidate 2 (CASC2) for Chronic Renal Failure in Patients with Type 2 Diabetes. Medical Science Monitor, 24, 6079-6084. https://doi.org/10.12659/MSM.909510
|
[47]
|
Gao, J., Wang, W., Wang, F. and Guo, C. (2018) LncRNA-NR_033515 Promotes Proliferation, Fibrogenesis and Epithelial-to-Mesenchymal Transition by Targeting miR-743b-5p in Diabetic Nephropathy. Biomedicine & Pharmacotherapy, 106, 543-552. https://doi.org/10.1016/j.biopha.2018.06.104
|
[48]
|
Zhang, R., Li, J., Huang, T. and Wang, X. (2017) Danggui Buxue Tang Suppresses High Glucose-Induced Proliferation and Extracellular Matrix Accumulation of Mesangial Cells via Inhibiting LncRNA PVT1. American Journal of Translational Research, 9, 3732-3740.
|
[49]
|
汪佳佳. 小檗碱对糖尿病肾病足细胞保护作用及对长链非编码RNA的初步调节作用研究[D]: [硕士学位论文]. 合肥: 安徽医科大学, 2021.
|
[50]
|
周学锋. 糖肾方改善糖尿病肾脏纤维化和氧化应激损伤的机制研究[D]: [博士学位论文]. 北京: 北京中医药大学, 2021.
|
[51]
|
林晓, 李健春, 谭睿陟, 文丹, 谢席胜, 王丽. 黄芪三七合剂通过调控Arid2-IR/NF-κB信号轴改善糖尿病肾病小鼠肾炎症反应[J]. 中国实验动物学报, 2020, 28(3): 382-389.
|
[52]
|
杜华. 益肾颗粒调控LncRNA MALAT1/mTOR诱导足细胞自噬改善糖尿病肾病的机制研究[D]: [博士学位论文]. 北京: 中国中医科学院, 2020.
|
[53]
|
Yi, Y., Zhao, Y., Huang, Y. and Wang, D. (2017) A Brief Review of RNA-Protein Interaction Database Resources. Noncoding RNA, 3, 6. https://doi.org/10.3390/ncrna3010006
|